I joined Moorfields as a surgical fellow in 2006, and was promoted to consultant in 2009. Before this, I ran clinical trials in glaucoma surgery in Singapore where I worked with Professor Sir Peng Khaw, who is now Moorfields’ director of research. It was this experience which nurtured my interest in the potential of clinical trials to really improve treatments for patients and I moved to Moorfields to continue this work.
My research focuses on interrogating existing treatments for glaucoma to determine if they are the most appropriate and effective ones for the patient. If you analyse which glaucoma treatments are prescribed, it is possible to find variations based on things like the patients’ locations, or the training the clinician has had. These things mean that treatment decisions often aren’t as rational as you may think. I want to provide the data that enables clinicians to make truly evidence based decisions which will lead to the best outcomes for our patients.
For example, I am currently leading a study looking at whether using a laser treatment to treat glaucoma is a more effective or more cost effective way of reducing intra-ocular pressure than using eye drops. I believe the LiGHT study, which is partially supported by Moorfields Eye Charity, has the potential to produce findings which we can use to improve our patient’s vision and quality of life, while also saving the NHS valuable time and money.
One of the truly special things about working at Moorfields is that everyone is invested in research and the potential it has to bring tremendous benefits to our patients. It’s wonderful to be part of a team that truly respects this and is working together, in conjunction with our partners at the UCL Institute of Ophthalmology, to support the research programme. The joy this hospital takes in doing research is unusual and very productive.
For our patients, it means they are part of world class research and clinical trials they’d never otherwise have access to. Participating in these new treatments and carefully conducted studies is not only an opportunity for patients to benefit themselves, but are also a wonderful means for them to benefit others like them around the world.
To find out more about Mr Gazzard, please visit his website.